SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:3ae596f1-8681-4943-9401-b1a8a77f4a17"
 

Search: onr:"swepub:oai:lup.lub.lu.se:3ae596f1-8681-4943-9401-b1a8a77f4a17" > Development of the ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Development of the ClinESSDAI : A clinical score without biological domain. A tool for biological studies

Seror, Raphaèle (author)
University of Paris-Saclay
Meiners, Petra (author)
University of Groningen
Baron, Gabriel (author)
Paris Descartes University
show more...
Bootsma, Hendrika (author)
University of Groningen
Bowman, Simon J. (author)
University Hospitals Birmingham
Vitali, Claudio (author)
Instituto San Giuseppe Como
Gottenberg, Jacques Eric (author)
University of Strasbourg
Theander, Elke (author)
Lund University,Lunds universitet,Internmedicin - epidemiologi,Forskargrupper vid Lunds universitet,Internal Medicine - Epidemiology,Lund University Research Groups,Skåne University Hospital
Tzioufas, Athanasios (author)
National and Kapodistrian University of Athens
De Vita, Salvatore (author)
University of Udine
Ramos-Casals, Manel (author)
Hospital Clínic of Barcelona
Dörner, Thomas (author)
Charité - University Medicine Berlin
Quartuccio, Luca (author)
University of Udine
Ravaud, Philippe (author)
Paris Descartes University
Mariette, Xavier (author)
University of Paris-Saclay
show less...
 (creator_code:org_t)
2016-01-25
2016
English 6 s.
In: Annals of the Rheumatic Diseases. - : BMJ. - 0003-4967 .- 1468-2060. ; 75:11, s. 1945-1950
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Objective To develop and validate ClinESSDAI (Clinical European League Against Rheumatism Sjögren's Syndrome Disease Activity Index), ie, ESSDAI without the biological domain. Patients and methods The 702 fictive vignettes derived from 96 real cases of primary Sjögren's syndrome of the ESSDAI development study were used. As for ESSDAI development, the physician assessment of disease activity (0-10 scale) was used as the â € gold standard' in a multivariate model for weighting domains, after removing the biological domain. The reliability, assessed by intraclass correlation coefficient (ICC) between ClinESSDAI and ESSDAI, explored if ClinESSDAI was equivalent to ESSDAI. Its psychometric (ie, measurement) properties were compared with that of ESSDAI in an independent cohort. Also, its use was evaluated on data of two clinical trials. Results In multivariate modelling, all 11 domains remained significantly associated with disease activity, with slight modifications of some domain weights. Reliability between clinESSDAI and ESSDAI was excellent (ICC=0.98 and 0.99). Psychometric properties of clinESSDAI, disease activity levels and minimal clinically important improvement thresholds and its ability to detect change over time in clinical trials were very close to that of ESSDAI. Conclusions ClinESSDAI appears valid and very close to the original ESSDAI. This score provides an accurate evaluation of disease activity independent of B-cell biomarkers. It could be used in various circumstances: (i) in biological/clinical studies to avoid data collinearity, (ii) in clinical trials, as secondary endpoint, to detect change independent of biological effect of the drug, (iii) in clinical practice to assess disease activity for visits where immunological tests have not been done.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Reumatologi och inflammation (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Rheumatology and Autoimmunity (hsv//eng)

Keyword

Disease Activity
Outcomes research
Sjøgren's Syndrome

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view